SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-218012
Filing Date
2019-08-09
Accepted
2019-08-09 16:21:03
Documents
61
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d783309d10q.htm 10-Q 675284
2 EX-31.1 d783309dex311.htm EX-31.1 6529
3 EX-31.2 d783309dex312.htm EX-31.2 6342
4 EX-32.1 d783309dex321.htm EX-32.1 6212
  Complete submission text file 0001193125-19-218012.txt   4347741

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cfrx-20190630.xml EX-101.INS 1026480
6 XBRL TAXONOMY EXTENSION SCHEMA cfrx-20190630.xsd EX-101.SCH 37842
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cfrx-20190630_cal.xml EX-101.CAL 35409
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cfrx-20190630_def.xml EX-101.DEF 133756
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cfrx-20190630_lab.xml EX-101.LAB 329665
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cfrx-20190630_pre.xml EX-101.PRE 252087
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36577 | Film No.: 191013232
SIC: 2834 Pharmaceutical Preparations